Herman Nilsson‐Ehle

4.3k total citations
58 papers, 2.1k citations indexed

About

Herman Nilsson‐Ehle is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Herman Nilsson‐Ehle has authored 58 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pathology and Forensic Medicine, 18 papers in Genetics and 17 papers in Oncology. Recurrent topics in Herman Nilsson‐Ehle's work include Lymphoma Diagnosis and Treatment (24 papers), Viral-associated cancers and disorders (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Herman Nilsson‐Ehle is often cited by papers focused on Lymphoma Diagnosis and Treatment (24 papers), Viral-associated cancers and disorders (10 papers) and Chronic Lymphocytic Leukemia Research (9 papers). Herman Nilsson‐Ehle collaborates with scholars based in Sweden, Denmark and United States. Herman Nilsson‐Ehle's co-authors include Sten Landahl, Catharina Lewerin, R Jagenburg, Per‐Ola Andersson, Jan Westin, Sverker Hasselblom, Alvar Svanborg, Ulrika Hansson, Börje Ridell and Mats Jerkeman and has published in prestigious journals such as Journal of Clinical Oncology, Blood and American Journal of Clinical Nutrition.

In The Last Decade

Herman Nilsson‐Ehle

58 papers receiving 2.0k citations

Peers

Countries citing papers authored by Herman Nilsson‐Ehle

Since Specialization

Citations

This map shows the geographic impact of Herman Nilsson‐Ehle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Herman Nilsson‐Ehle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Herman Nilsson‐Ehle more than expected).

Fields of papers citing papers by Herman Nilsson‐Ehle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Herman Nilsson‐Ehle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Herman Nilsson‐Ehle. The network helps show where Herman Nilsson‐Ehle may publish in the future.

Co-authorship network of co-authors of Herman Nilsson‐Ehle

This figure shows the co-authorship network connecting the top 25 collaborators of Herman Nilsson‐Ehle. A scholar is included among the top collaborators of Herman Nilsson‐Ehle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Herman Nilsson‐Ehle. Herman Nilsson‐Ehle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Trends in the prevalence, incidence and survival of non‐Hodgkin lymphoma subtypes during the 21st century – a Swedish lymphoma register study 2020 ·British Journal of Haematology ·Sara Ekberg, Karin E. Smedby, Ingrid Glimelius, Herman Nilsson‐Ehle, (unknown), Catharina Lewerin, Mats Jerkeman, Sandra Eloranta	21
2	Evaluating the implementation and use of the regional cancer plan in Western Sweden through concept mapping 2018 ·International Journal for Quality in Health Care ·(unknown), K. Gunnarsdóttir, Anna Genell, Daniel McLinden, Lisa M. Vaughn, Hege Garelius, Herman Nilsson‐Ehle, (unknown), Thomas Björk‐Eriksson	4
3	Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression 2018 ·Haematologica ·John F. Seymour, Robert Marcus, Andrew Davies, Eve Gallop‐Evans, (unknown), Andrew Haynes, Michael Herold, Thomas Illmer, Herman Nilsson‐Ehle, Martin Sökler, (unknown), Tina Nielsen, Aino Launonen, Wolfgang Hiddemann	69
4	Low serum iron is associated with high serum intact FGF23 in elderly men: The Swedish MrOS study 2017 ·Bone ·Catharina Lewerin, Östen Ljunggren, Herman Nilsson‐Ehle, Magnus K. Karlsson, Hans Herlitz, Mattias Lorentzon, Claes Ohlsson, Dan Mellström	39
5	Serum nuclear magnetic resonance-based metabolomics and outcome in diffuse large B-cell lymphoma patients – a pilot study 2016 ·Leukemia & lymphoma ·(unknown), Anders Pedersen, Sverker Hasselblom, Herman Nilsson‐Ehle, Göran Karlsson, Rui Pinto, Per‐Ola Andersson	16
6	Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study 2014 ·Leukemia ·(unknown), Stefan Peterson, Eva Kimby, Sandra Lockmer, O. Lindén, Herman Nilsson‐Ehle, Martin Erlanson, Hans Hagberg, (unknown), Oskar Hagberg, Björn E. Wahlin	95
7	T Cells in Tumors and Blood Predict Outcome in Follicular Lymphoma Treated with Rituximab 2011 ·Clinical Cancer Research ·Björn E. Wahlin, Christer Sundström, Harald Holte, Hans Hagberg, Martin Erlanson, Herman Nilsson‐Ehle, Ola Lindén, Marie Nordström, Bjørn Østenstad, Christian H. Geisler, Peter de Nully Brown, Tuula Lehtinen, (unknown), Anne Tierens, Birgitta Sander, Birger Christensson, Eva Kimby	41
8	Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions 2011 ·European Journal Of Haematology ·Herman Nilsson‐Ehle, Gunnar Birgegård, Jan Samuelsson, Petar Antunović, Jan Astermark, Hege Garelius, (unknown), Lars Kjeldsen, Lars Nilsson, Anna Olsson, (unknown), Jonas Wallvik, Nina Gulbrandsen, Eva Hellström‐Lindberg	49
9	Improved outcome for very elderly patients with diff use large B-cell lymphoma in the immunochemotherapy era 2011 ·Leukemia & lymphoma ·Sverker Hasselblom, (unknown), (unknown), Monica Sender, Catharina Lewerin, Ulrika Hansson, Herman Nilsson‐Ehle, Per‐Ola Andersson	20
10	Expression of CD68+ tumor‐associated macrophages in patients with diffuse large B‐cell lymphoma and its relation to prognosis 2008 ·Pathology International ·Sverker Hasselblom, Ulrika Hansson, Margrét Sigurðardóttir, Herman Nilsson‐Ehle, Börje Ridell, Per‐Ola Andersson	63
11	Low rather than high Ki-67 protein expression is an adverse prognostic factor in diffuse large B-cell lymphoma 2008 ·Leukemia & lymphoma ·Sverker Hasselblom, Börje Ridell, Margrét Sigurðardóttir, Ulrika Hansson, Herman Nilsson‐Ehle, Per‐Ola Andersson	36
12	Glomerular filtration rate as measured by serum cystatin C is an important determinant of plasma homocysteine and serum methylmalonic acid in the elderly 2007 ·Journal of Internal Medicine ·Catharina Lewerin, Susanne Ljungman, Herman Nilsson‐Ehle	44
13	The number of tumour‐infiltrating TIA‐1+ cytotoxic T cells but not FOXP3+ regulatory T cells predicts outcome in diffuse large B‐cell lymphoma 2007 ·British Journal of Haematology ·Sverker Hasselblom, (unknown), Ulrika Hansson, Herman Nilsson‐Ehle, Börje Ridell, Per‐Ola Andersson	58
14	The expression of NK cell inhibitory receptors on cytotoxic T cells in B-cell chronic lymphocytic leukaemia (B-CLL) 2006 ·Annals of Hematology ·Katarina Junevik, (unknown), Sverker Hasselblom, Stefan Jacobsson, Herman Nilsson‐Ehle, Per‐Ola Andersson	9
15	Insulin‐like growth factor‐1 is a predictor of blood haemoglobin concentration in 70‐yr‐old subjects 2005 ·European Journal Of Haematology ·Herman Nilsson‐Ehle, (unknown), Göran Lindstedt, Dan Mellström	22
16	Significant correlations of plasma homocysteine and serum methylmalonic acid with movement and cognitive performance in elderly subjects but no improvement from short-term vitamin therapy: a placebo-controlled randomized study 2005 ·American Journal of Clinical Nutrition ·Catharina Lewerin, Michael Matousek, (unknown), Boo Johansson, Bertil Steen, Herman Nilsson‐Ehle	104
17	Trofosfamide as Salvage Therapy for Anaplastic Large Cell Lymphoma Relapsing After High-dose Chemotherapy 2002 ·Leukemia & lymphoma ·Per‐Ola Andersson, (unknown), Herman Nilsson‐Ehle	8
18	Blood haemoglobin declines in the elderly: implications for reference intervals fromage 70 to 88 2000 ·European Journal Of Haematology ·Herman Nilsson‐Ehle, R Jagenburg, Sten Landahl, Alvar Svanborg	106
19	Bone marrow progenitor cell growth and karyotype changes in healthy 88‐year‐old subjects 1995 ·European Journal Of Haematology ·Herman Nilsson‐Ehle, Birgitta Swolin, Jan Westin	22
20	Low serum cobalamin levels in a population study of 70- and 75-year-old subjects 1989 ·Digestive Diseases and Sciences ·Herman Nilsson‐Ehle, Sten Landahl, (unknown), (unknown), R. W. Stockbruegger, Jan Westin, (unknown)	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact